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ABSTRACT
Objectives: The extent to which aspects of sleep
affect well-being in the long-term remains unclear. This
longitudinal study examines the association between
chronic insomnia symptoms, recurrent sleep duration
and well-being at older ages.
Setting: A prospective cohort of UK civil servants (the
Whitehall II study).
Participants: 4491 women and men (25.2% women)
with sleep measured 3 times over 10 years and well-
being once at age 55–79 years. Insomnia symptoms
and sleep duration were assessed through self-reports
in 1997–1999, 2003–2004 and 2007–2009.
Primary outcome measures: Indicators of well-
being, measured in 2007–2009, were the Control,
Autonomy, Self-realisation and Pleasure measure
(CASP-19) of overall well-being (range 0–57) and the
physical and mental well-being component scores
(range 0–100) of the Short Form Health Survey (SF-36).
Results: In maximally adjusted analyses, chronic
insomnia symptoms were associated with poorer overall
well-being (difference between insomnia at 3
assessments vs none −7.0 (SE=0.4) p<0.001), mental
well-being (difference −6.9 (SE=0.4), p<0.001) and
physical well-being (difference −2.8 (SE=0.4), p<0.001)
independently of the other sleep measures. There was a
suggestion of a dose–response pattern in these
associations. In addition, recurrent short sleep
(difference between ≤5 h sleep reported at 3
assessments vs none −1.7 (SE=0.7), p<0.05) and
recurrent long sleep (difference between >9 h reported
at 2 or 3 assessments vs none −3.5 (SE=0.9), p<0.001)
were associated with poorer physical well-being.
Conclusions: We conclude that in older people,
chronic insomnia symptoms are negatively associated
with all aspects of well-being, whereas recurrent long
and short sleep is only associated with reduced
physical well-being.
INTRODUCTION
Insomnia symptoms, short (≤5 h/night) and
long (≥9 h/night) sleep are all associated
with an increased risk of a range of chronic
health conditions, such as diabetes,1–3 hyper-
tension4 and mortality.5 6 Health is an
important predictor of well-being; however,
overall well-being is often more than merely
the absence of poor physical or mental ill
health. This is particularly the case in older
populations, where there is a high preva-
lence of chronic diseases.
Cross-sectional research on the contribu-
tion of sleep to well-being indicates that
insomnia symptoms7–9 and both short and
long sleep10–12 are associated with lower
levels of well-being. Evidence for an inter-
action between insomnia symptoms, sleep
duration and health has also been sug-
gested.13 However, what has been studied less
is whether these cross-sectional associations
strengthen when insomnia symptoms and
extreme sleep duration are based on
repeated assessments. A recent study mea-
sured chronic insomnia symptoms at two
time points, using a conservative estimate;
Strengths and limitations of this study
▪ So far most evidence on the association between
quality sleep and well-being has been drawn
from cross-sectional data and has focused on
health-related well-being measures.
▪ Strengths of this study include the availability of
repeat measures of sleep duration and insomnia
symptoms and three validated well-being scales
to consider different domains of well-being.
▪ It suggests that there are long-term effects of
insomnia symptoms for the well-being of older
people. However, negative effects of extreme
sleep duration are only seen for physical
well-being.
▪ A limitation of this study is that these sleep mea-
sures are self-reported. Although observational
are beginning to utilise actigraphy methods,
these were not available over such a long time
period.
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the lowest frequency of insomnia symptoms mentioned
at either of the time points.8 The study found that these
had a strong negative association with subjective
well-being.
The relationship between sleep and well-being might
also vary with the outcome measure examined. In previ-
ous work there has been an emphasis on measures
which capture health-related well-being, such as the
Short Form (SF-36) Health Survey.14 However, this may
not fully capture well-being in elderly populations, since
it reﬂects mental and physical functioning which decline
in older age groups.15 To evaluate overall well-being in
early old age, the Control, Autonomy, Self-realisation
and Pleasure (CASP-19) measure was developed. It eval-
uates quality of life as distinct from factors which predict
it, such as good health.16
To the best of our knowledge, no other studies have
been able to provide repeat measurements taken over a
10-year follow-up period. To address these limitations of
previous work, we examine reports of chronic insomnia
symptoms and recurrent extreme sleep duration with
well-being in old age. Our two key objectives are: (1) to
examine whether chronic insomnia symptoms and recur-
rent short or long sleep duration are independently
associated with well-being in older adults and (2) to
determine whether the associations between sleep and
well-being extend to three different domains: overall
well-being (CASP-19), physical well-being (SF-36: PCS)
and mental well-being (SF-36: MCS).
METHODS
Study sample
The Whitehall II Cohort was recruited from
London-based Civil Service departments in 1985–1988
(phase 1), the sample consisted of 10 308 participants
aged 35–55, with a response rate of 73%. Follow-up
screening examinations took place in 1991–1993 (phase
3) and 1997–1999 (phase 5), 2003–2004 (phase 7) and
2007–2009 (phase 9) with postal questionnaires being
sent to participants in 1989 (phase 2), 1995 (phase 4),
2001 (phase 6) and 2006 (phase 8). Further details of
the Whitehall II Study can be found elsewhere.17 In this
study, we used sleep exposure data from 1997–1999,
2003–2004 and 2007–2009 to predict well-being in 2007–
2009, when the participants were aged 55–79 years. A
total of 6761 respondents participated in phase 9, a
response rate of 66% since phase 1, but 86% from those
eligible at phase 9. The follow-up rate from phases 5 to
9 was 85.9%. The ﬁnal sample of 4491 (1133 women;
25.2%) participated at phase 9 and had complete infor-
mation for all relevant variables.
Well-being outcomes
The following outcome measures reported at phase 9
(2007–2009) were used in the analysis:
Overall well-being (CASP-19): CASP-19 is an instrument
developed and validated to measure overall well-being
in older people, independent of inﬂuencing factors
such as health.18 CASP-19 sums 19 Likert-scaled items,
measuring Control, Autonomy, Self-realisation and
Pleasure. Testing carried out on CASP-19 during its
development is reported elsewhere.19 Respondents
were asked to indicate how often each statement
applied to them; often, sometimes, not often or never, and
these scores were appropriately coded, using a sliding
scale of 0–3 and summed (range 0–57), with higher
scores indicating a better quality of life.19 20 The scale
had good internal consistency at phase 9 (2007–2009;
Cronbach’s α=0.88).
Physical and mental well-being (SF-36): SF-36 is a 36-item
questionnaire; these questions are used to construct
the eight SF-36 scales: physical functioning, mental
functioning, role limitations due to physical problems,
social functioning, bodily pain, role limitations due to
emotional problems, vitality and general health per-
ceptions.21 These eight scales can be aggregated to
form two summary scores—physical and mental func-
tioning component scores—using a method based on
factor analysis. They are considered to be conceptually
distinct measures of physical (SF-36: PCS) and mental
well-being (SF-36: MCS).14 21 Scores for each of these
two scales ranged from 0 to 100, with higher scores
indicating greater well-being. The correlation between
CASP-19 and SF-36 mental well-being was r=0.64
(p≤0.001) and the correlation between CASP-19 and
SF-36 physical well-being was r=0.39 (p≤0.001).
Measures of sleep
Insomnia symptoms were measured at the same phases as
sleep duration using the Jenkins’ sleep problem scale.22
Participants were asked how many times during the last
month they: (1) ‘have trouble falling asleep’, (2) ‘have
trouble staying asleep (ie, waking up far too early)’, (3)
‘wake up several times per night’ and (4) ‘wake up after
usual amount of sleep feeling tired and worn out’. The
following response categories were available: not at all,
1–3, 4–7, 8–14, 15–21 and 22–31 days. This scale was
summed and grouped into quartiles. The ﬁrst three
quartiles were grouped together (low insomnia symp-
toms) and the fourth quartile was grouped separately
(high insomnia symptoms). Chronic insomnia symptoms
were deﬁned as the number of times, across the three
time points that a participant reported high insomnia
symptoms. The length of follow-up from the ﬁrst sleep
exposure to outcome ranged from 8 to 12 years (mean
9.8 years).
Sleep duration was self-reported and measured at phase
5 (1997–1999), phase 7 (2003–2004) and phase 9
(2007–2009) using the question: ‘How many hours of
sleep do you have on an average week night?’; with the
options 5 h or less, 6, 7, 8 or 9 h or more. Cross-sectional
research (see online supplementary table S1) conﬁrmed
evidence from previous literature, that extreme sleep
duration has the greatest impact on health and well-
being, therefore only short and long sleep was examined
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longitudinally. Two variables were created using data
from each time point: (1) recurrent short sleep, deﬁned
as the number of times a participant reported short
(≤5 h/night) sleep across the three time points; (2)
recurrent long sleep, deﬁned as the number of times a
participant reported long sleep (≥9 h/night) across the
three time points.
Covariates
A range of covariates, measured at phase 9 (2007–2009),
were also included: gender and age were considered to be
confounding factors. A quadratic term for age (age2)
was included because the relationship of age to CASP-19
has been shown to follow a non-linear trend.16
Participants were asked to estimate their total household
wealth (including house value); this was recoded into
four categories (1) <£200 000, (2) £200–£499 999, (3)
£500–£999 999 and (4) >£1 000 000. Household wealth
rather than civil service employment grade or income
was used since it has been shown to represent the eco-
nomic status of older people more accurately than
income.23 A binary variable indicated whether the par-
ticipant was still in paid employment. Marital status was
deﬁned as married/cohabiting or not. Chronic health con-
ditions were assessed as the presence or absence of a lim-
iting long-term illness. Poor functioning was deﬁned as
limitations in one or more activities of daily living
(ADL), or one or more instrumental ADL (IADL).
Health behaviours: smoking (current vs never/
ex-smokers), physical activity; based on the duration of
‘vigorous’ activity (≥1.5 vs <1.5 h per week). Physical
activity was assessed using a questionnaire which asked
participants about the number of hours spent undertak-
ing a range of physical activity (both leisure time and
job-related activities). Each activity was assigned a meta-
bolic equivalent (MET) value.24 Vigorous physical activ-
ity was deﬁned as activities with a MET value of 6 or
more25 (eg, swimming, mowing). High alcohol con-
sumption (≥14 units/week for women and ≥22 units/
week for men) and body mass index (BMI): height and
weight were measured during the medical examination
and BMI (kg/m2) calculated. Depressive symptoms were
assessed using a modiﬁed version of the 30-item General
Health Questionnaire (GHQ)26 removing the two ques-
tions that referred to sleep problems. Higher GHQ
scores indicate more depressive symptoms.
Statistical analysis
Pearson’s χ2 test for homogeneity (4df) was used to
examine this association between sleep duration and
each categorical covariate, while linear regression was
used for continuous exposures to examine heterogeneity
across the sleep duration categories. We also conducted
a non-parametric test of trend for each well-being
outcome, across the groups of each exposure variable.
We used the Stata command nptrend which is an exten-
sion of the Wilcoxon rank-sum test. Three models were
estimated using the exposures for recurrent short and
long sleep and chronic insomnia symptoms. In the ﬁrst
model age, age2, gender and household wealth were
included. In model 2 employment status, marital status,
chronic health conditions, ADL/IADL and health beha-
viours were additionally included. In model 3, the
remaining sleep exposure was also added to model
2. Since the association between overall well-being, or
physical well-being and poor sleep might be confounded
by mental health, further models were adjusted for the
depressive symptoms score. Statistical signiﬁcance levels
were set at p<0.05 for two-sided analyses. Each exposure
variable was also examined cross-sectionally; these results
are available in online supplementary tables S1 and S2
and the results reported in the text. In the cross-
sectional analysis, the full ﬁve-category measure of sleep
duration was tested and each item of the insomnia symp-
toms scale examined separately. In the cross-sectional
models, a reference group of 7 h was used.27 All analyses
were undertaken using Stata V.13.1.
RESULTS
The distribution of participant characteristics, by sleep
duration reported in 2007–2009 is reported in table 1.
In this sample, the mean (SD) overall well-being score
was 43.5 (7.8), the mean physical well-being score was
49.0 (8.5) and the mean mental well-being score was
53.9 (7.9). The percentage of those participants who
reported high levels of insomnia symptoms at each of
the three time points was 8.2% (N=368); in 2007–2009,
7.5% (N=335) participants reported short sleep and
2.1% (N=94) long sleep. An inverted U-shaped associ-
ation with sleep duration was observed for each of these
outcomes. Those who reported shorter and longer sleep
were also more likely to have a long-term illness and
have one or more ADLs and IADLs. Those who reported
sleeping 5 h or less were more likely to be younger,
female and to have worked or be currently working in
the lowest civil service employment grade, but were less
likely to be married or cohabiting. They were also more
likely to have a high BMI, less likely to report undertak-
ing any vigorous physical activity and more likely to
score highly on the GHQ depression scale and report
high levels of insomnia symptoms.
In the cross-sectional linear regression analyses (see
online supplementary tables S1 and S2), the binary
measure of high levels of insomnia symptoms was asso-
ciated with lower levels of all the well-being measures in
each of the models. These associations were attenuated
when covariates were included, especially for the
measure of physical well-being. Negative associations
were also observed between each of the three outcome
measures and each item of the Jenkins sleep scale, when
these were included in the analysis individually. A nega-
tive association between short sleep (≤5 or 6 h) was
observed for both mental well-being and overall well-
being when compared with those who report sleeping
7 h a night. However, a strong U-shaped association was
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observed between sleep duration and physical well-being
SF-36 (PCS) in all three models, with both short (≤5 h)
and long (≥9) sleep being associated with worse physical
well-being.
Table 2 shows the results for recurrent short sleep,
recurrent long sleep and chronic insomnia symptoms
with well-being. A test for trend showed a trend of each
well-being outcome across the occurrence of insomnia
symptoms (CASP-19, p≤0.001; SF-36 (PCS), p≤0.001;
SF-36 (MCS), p≤0.001). When chronic insomnia symp-
toms were examined in regression analysis a dose–
response association was observed for each well-being
outcome, with each additional occurrence of high levels
of insomnia symptoms increasing the negative effect.
This association remained in all three models, although
the association was attenuated in the fully adjusted
model. In models 1 and 2 recurrent short sleep (≤5 h)
was associated with poorer overall well-being, with a
small dose–response relationship suggested. A test of
trend analysis indicated a trend for each of the well-
being outcomes across the occurrences of short sleep
(CASP-19, p≤0.001; SF-36 (PCS), p≤0.001; SF-36 (MCS),
p≤0.001). However, when chronic insomnia symptoms
were also included in the analysis, this association was
attenuated substantially.
A similar pattern of results were observed for mental
well-being. However, for physical well-being the associ-
ation between three reported occurrences of short
sleep, although attenuated, remained in model 3. The
results for reported recurrent long sleep (≥9 h) showed
that one occurrence was associated with both lower
overall and mental well-being, although this was attenu-
ated by model 3 for overall well-being. However, for
physical well-being there was a negative association
between two or more occurrences of long sleep, which
although attenuated, remained in each of the three
models. A test of trend for well-being outcomes over the
occurrences of long sleep was only signiﬁcant for phys-
ical well-being (SF-36 (PCS), p=0.011).
Table 3 shows the association of the three sleep expo-
sures with overall, physical and mental well-being after
further adjustment for the potential confounding effects of
depression. Model 3 (from table 2) is additionally adjusted
for the modiﬁed GHQ-30 depressive symptom score.
Table 1 Characteristics of participants by sleep duration 2007–2009 (N=4491)
Hours of sleep
All ≤5 6 7 8 ≥9 p Value*
Sleep duration, % (N) 7.5 (335) 29.0 (1303) 41.8 (1875) 19.7 (884) 2.1 (94)
Age (years), mean (SD)† 65.6 (5.9) 66.5 (6.1) 65.5 (5.9) 65. 4 (5.8) 66.1 (5.7) 67.4 (6.2) <0.0001
Women, % (N) 25.2 (1133) 36.4 (122) 26.9 (351) 24.6 (461) 20.1 (178) 22.3 (21) <0.0001
Married, % (N) 76.8 (3449) 58.8 (197) 74.2 (967) 79.4 (1489) 81.8 (723) 77.7 (73) <0.0001
Employed, % (N) 31.5 (1414) 28.7 (96) 36.9 (481) 34.1 (640) 20.9 (185) 12.8 (12) <0.0001
Lowest wealth (<£200 000), % (N) 9.3 (419) 17.9 (60) 10.1 (132) 8.8 (164) 6.5 (57) 6.4 (6) <0.0001
High alcohol consumption, % (N) 17.8 (800) 13.4 (45) 17.2 (224) 17.6 (330) 19.9 (176) 26.6 (25) 0.015
Vigorous physical activity, % (N) 13.3 (595) 9.3 (31) 12.0 (156) 13.4 (251) 16.4 (145) 12.8 (12) 0.007
Current smoking, % (N) 6.3 (283) 5.4 (18) 5.4 (70) 6.7 (125) 7.1 (63) 7.5 (7) 0.366
BMI (kg/m2), mean (SD)† 26.6 (4.3) 27.4 (4.5) 27.0 (4.6) 26.5 (4.2) 26.1 (4.0) 26.7 (4.6) <0.0001
No long-term illness, % (N) 34.6 (1555) 24.5 (82) 33.5 (437) 35.9 (673) 37.6 (332) 33.0 (31) <0.0001
One or more ADL % (N) 8.5 (382) 15.8 (53) 10.3 (134) 6.8 (128) 6.3 (56) 11.7 (11) <0.0001
One or more IADL % (N) 12.4 (555) 21.8 (73) 14.4 (188) 10.2 (192) 9.3 (82) 21.3 (20) <0.0001
GHQ (modified), mean (SD) † 1.9 (4.1) 4.0 (6.1) 2.3 (4.5) 1.5 (3.6) 1.3 (3.1) 2.0 (3.8) <0.0001
High insomnia symptoms, % (N) 32.5 (1461) 64.5 (216) 37.2 (484) 27.1 (508) 25.0 (221) 34.0 (32) <0.0001
Chronic insomnia symptoms, % (N)‡
No occurrence 63.3 (2842) 26.0 (87) 53.0 (690) 70.9 (1329) 76.4 (675) 64.9 (61) <0.0001
One occurrence 17.4 (782) 20.6 (69) 20.6 (269) 15.3 (286) 15.8 (140) 19.2 (18) <0.0001
Two occurrences 11.1 (499) 22.4 (75) 15.4 (200) 9.4 (176) 4.9 (43) 5.3 (5) <0.0001
Three occurrences 8.2 (368) 31.0 (104) 11.06 (144) 4.5 (84) 2.9 (26) 10.6 (10) <0.0001
Trouble falling asleep, %(N) 3.1 (140) 20.0 (67) 3.3 (43) 1.1 (20) 1.0 (9) 1.1 (1) <0.0001
Waking in the night, % (N) 28.4 (1275) 54.0 (181) 31.5 (411) 23.9 (448) 23.3 (206) 30.9 (29) <0.0001
Waking up tired, % (N) 7.1 (317) 26.6 (89) 8.0 (104) 4.4 (83) 3.4 (30) 11.7 (11) <0.0001
Trouble staying asleep, % (N) 13.1 (588) 52.2 (175) 18.9 (246) 6.8 (128) 3.7 (33) 6.4 (6) <0.0001
CASP-19, mean (SD)† 43.5 (7.8) 38.7 (9.2) 42.4 (7.8) 44.4 (7.2) 45.0 (7.1) 42.8 (8.1) <0.0001
SF-36 (PCS), mean (SD)† 49.0 (8.5) 45.5 (10.5) 48.4 (9.1) 49.7 (7.9) 49.8 (7.8) 46.1 (8.8) <0.0001
SF-36 (MCS), mean (SD)† 53.9 (7.9) 50.0 (10.6) 53.2 (8.2) 54.5 (7.3) 55.0 (6.8) 53.7 (8.7) <0.0001
*p Value for heterogeneity.
†Mean (SD).
‡Number of times (1997–1999, 2003–2004 and 2007–2009) high level of insomnia symptoms reported.
ADL, activities of daily living; BMI, body mass index; CASP-19, Control, Autonomy, Self-realisation and Pleasure measure; GHQ, General
Health Questionnaire; IADL, instrumental activities of daily living; SF-36 (MCS), Short Form Health Survey mental well-being component
scores; SF-36 (PCS), Short Form Health Survey physical component scores.
4 Abell JG, et al. BMJ Open 2016;6:e009501. doi:10.1136/bmjopen-2015-009501
Open Access
group.bmj.com on April 6, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Table 2 Association of recurrent sleep duration and insomnia symptoms with overall well-being, physical well-being and mental well-being
N=4,491
Overall well-being b† Physical well-being‡ Mental well-being§
Model 1
Diff¶ (SE)
[standardised
difference]
Model 2
Diff¶ (SE)
[standardised
difference]
Model 3
Diff¶ (SE)
[standardised
difference]
Model 1
Diff¶ (SE)
[standardised
difference]
Model 2
Diff¶ (SE)
[standardised
difference]
Model 3
Diff¶ (SE)
[standardised
difference]
Model 1
Diff¶ (SE)
[standardised
difference]
Model 2
Diff¶ (SE)
[standardised
difference]
Model 3
Diff¶ (SE)
[standardised
difference]
Recurrent short sleep††
No short sleep
(N=3869)
0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF
One occurrence
(N=372)
−3.23 (0.41)
[−0.11] ***
−2.61 (0.39)
[−0.09] ***
−0.96 (0.38)
[−0.03]**
−2.28 (0.44)
[−0.07] ***
−0.75 (0.37)
[−0.02] *
0.01 (0.37)
[−0.00]
−2.56 (0.42)
[−0.09] ***
−2.34 (0.41)
[−0.08] ***
−0.69 (0.41)
[−0.02]
Two occurrences
(N=147)
−3.38 (0.63)
[−0.08] ***
−2.76 (0.60)
[−0.06] ***
−0.73 (0.58)
[−0.02]
−2.64 (0.69)
[−0.05] ***
−1.37 (0.57)
[−0.03] **
−0.56 (0.57)
[−0.01]
−1.91 (0.65)
[−0.04] ***
−1.57 (0.64)
[−0.04] **
0.43 (0.62)
[−0.01]
Three occurrences
(N=103)
−4.66 (0.75)
[−0.09] ***
−3.80 (0.71
[−0.07)***]
−0.84 (0.70)
[−0.01]
−4.59 (0.82)
[−0.08] ***
−2.83 (0.67)
[−0.05] ***
−1.68 (0.68)
[−0.03] **
−3.03 (0.78)
[−0.06] ***
−2.68 (0.76)
[−0.05] ***
0.21 (0.75)
[−0.00]
Recurrent long sleep ‡‡
No long sleep
(N=4302)
0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF
One occurrence
(N=134)
−1.86 (0.67)
[−0.04] **
−0.97 (0.63)
[−0.02]
−1.04 (0.60)
[−0.02]
−2.61 (0.72)
[−0.05] **
−0.67 (0.59)
[−0.01]
−0.67 (0.58)
[−0.01]
−1.77 (0.69)
[−0.04] *
−1.36 (0.67)
[−0.03] *
−1.41 (0.64)
[−0.03] *
Two or three
occurrences
(N=55)
0.68 (1.03)
[−0.01]
0.03 (0.97)
[−0.00]
0.43 (0.92)
[−0.01]
4.19 (1.11)
[−0.05] ***
3.33 (0.91)
[−0.04] ***
−3.52 (0.90)
[−0.05] ***
−0.91 (1.06)
[−0.01]
−0.38 (1.03)
[−0.01]
−0.78 (0.99)
[−0.01]
Chronic insomnia symptoms§§
No insomnia
symptoms
(N=2842)
0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF 0.00 REF
One occurrence
(N=782)
−3.22 (0.29)
[−0.16] ***
−2.83 (0.28)
[−0.14] ***
−2.72 (0.28)
[−0.13] ***
−2.74 (0.32)
[−0.12] ***
−1.53 (0.27)
[−0.07] ***
−1.53 (0.27)
[−0.07] ***
−2.94 (0.30)
[−0.14] ***
−2.88 (0.30)
[−0.14] ***
−2.81 (0.30)
[−0.13] ***
Two occurrences
(N=499)
−5.84 (0.34)
[−0.24] ***
−4.97 (0.33)
[−0.20] ***
−4.80 (0.34)
[−0.19] ***
−3.88 (0.39)
[−0.14] ***
−1.95 (0.33)
[−0.07]***
−1.88 (0.33)
[−0.07]***
−5.30 (0.36)
[−0.21] ***
−4.91 (0.36)
[−0.19] ***
−4.85 (0.36)
[−0.19) ***
Three occurrences
(N=368)
−8.60 (0.39)
[−0.30]***
−7.34 (0.38)
[−0.26] ***
−7.04 (0.40)
[−0.25] ***
−5.73 (0.45)
[−0.18] ***
−3.08 (0.38)
[−0.10] ***
−2.82 (0.39)
[−0.09] ***
−7.55 (0.41)
[−0.26] ***
−6.91(0.41)
[−0.24] ***
−6.88 (0.43)
[−0.24] ***
† Overall well-being (CASP-19).
‡Physical well-being (SF-36).
§Mental well-being (SF-36).
¶Difference (and SE) in well-being score from the reference group.
†† A test of trend analysis indicated a trend for each of the well-being outcomes across the occurrences of short sleep (CASP-19, p≤0.001; SF-36 (PCS), p≤0.001; SF-36 (MCS), p≤0.001).
‡‡ A test of trend for well-being outcomes over the occurrences of long sleep was only significant for physical well-being (SF-36 (PCS), p=0.011).
§§A test for trend showed a trend of each well-being outcome across the occurrence of insomnia symptoms, (CASP-19, p≤0.001; SF-36 (PCS), p≤0.001; SF-36 (MCS), p≤0.001). Figures in
square brackets show the difference in standardised well-being scores from the reference group. Model 1: adjusted for age, age2, gender, wealth; model 2: adjusted as in model 1+employment
status, marital status, limiting health conditions, physical functioning (ADL/IADL), health behaviours (alcohol, physical activity, smoking, BMI); model 3: adjusted as in model 2+insomnia
symptoms/recurrent long or short sleep. ***p≤0.001, **p≤0.01, * p<0.0.
ADL, activities of daily living; BMI, body mass index; CASP-19, Control, Autonomy, Self-realisation and Pleasure measure; IADL, instrumental activities of daily living; SF-36 (MCS), Short Form
Health Survey mental well-being component scores; SF-36 (PCS), Short Form Health Survey physical component scores.
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Overall, the pattern of ﬁndings observed previously
remains consistent, although the size of the association is
attenuated, especially for overall well-being. Online supple-
mentary table S3 compares the key characteristics of those
included and not included in the analyses. Although well-
being scores and participant characteristics were similar
between this sample and those excluded due to missing
data; chronic insomnia symptoms and recurrent short
sleep were more common and well-being poorer among
those not included in the analyses.
DISCUSSION
Prospective repeat data over 10 years of follow-up
suggest that insomnia symptoms and long sleep are inde-
pendently associated with lower levels of well-being, mea-
sured as overall well-being, physical and mental
well-being. There is a dose–response association between
chronic insomnia symptoms and poorer well-being, inde-
pendent of sleep duration and depressive symptoms.
However, the association between sleep duration and
well-being differed according to the measure of well-
being examined, possibly an indication that as societies
age, there may be less homogeneity in older age groups
and the correlates of well-being at older age may vary.
Our ﬁndings agree with previous research, which has
demonstrated independent negative associations,
between insomnia symptoms and lower physical and
mental well-being scores.28–34 We are not aware of any
studies that have examined the association between
chronic exposure to insomnia symptoms and the SF-36.
We found a dose–response association, suggesting that
recurrent exposure to insomnia was associated with both
lower mental and physical well-being.
Previous cross-sectional work has shown an association
between sleep duration and both mental and physical
well-being.10 35 We found that recurrent exposure to
long or short sleep was associated with poorer physical
well-being. However, we did not ﬁnd a prospective associ-
ation between sleep duration and mental well-being.
The association between recurrent short sleep and
mental well-being was no longer signiﬁcant after insom-
nia symptoms were taken into account. However, recur-
rent short sleep in the absence of high levels of
insomnia symptoms does not necessarily predict poor
well-being. Faubel et al10 also found that sleep duration
at baseline failed to predict change in mental well-being
2 years later.
Studies that have examined the relationship between
both short and long sleep with overall well-being have
generally reported an initial U-shaped relationship,11 12
which did not always remain after adjustment.12 This did
not accord with our cross-sectional ﬁndings, where only
short sleep was related to well-being. Additionally, we did
Table 3 Association of recurrent sleep duration and insomnia symptoms with well-being after further adjustment for
depressive symptoms†
N=4491
Overall well-being
Diff‡ (SE) [standardised
difference]
Physical well-being
Diff‡ (SE) [standardised
difference]
Mental well-being
Diff‡ (SE) [standardised
difference]
Recurrent short sleep
No short sleep 0.00 REF 0.00 REF 0.00REF
One occurrence −0.62 (0.35)
[−0.02]
0.01 (0.37)
[−0.00]
−0.12 (0.31)
[−0.01]
Two occurrences −0.72 (0.53)
[−0.02]
−0.56 (0.57)
[−0.01]
0.46 (0.48)
[0.01]
Three occurrences −0.55 (0.64)
[−0.01]
−1.63 (0.68)**
[−0.03]
0.70 (0.58)
[0.01]
Recurrent long sleep
No long sleep 0.00 REF 0.00 REF 0.00 REF
One occurrence −0.94 (0.54)
[−0.02]
−0.66 (0.58)
[−0.01]
−1.25 (0.49)*
[−0.03]
Two or three occurrences −0.14 (0.84)
[−0.00]
−3.47 (0.90) ***
[−0.04]
−0.30 (0.76)
[−0.00]
Chronic insomnia symptoms
No insomnia symptoms 0.00 REF 0.00 REF 0.00 REF
One occurrence −1.76 (0.26) ***
[−0.09]
−1.36 (0.27)***
[−0.06]
−1.22 (0.23)***
[0.06]
Two occurrences −3.28 (0.31)***
[−0.13]
−1.61 (0.33)***
[−0.06]
−2.31 (0.28)***
[−0.09]
Three occurrences −4.84 (0.37)***
[−0.17]
−2.41 (0.40)***
[−0.08]
−3.22 (0.34)***
[−0.11]
†Estimates are adjusted as in model 3 (see tables 3 and 4) with additional adjustment for depressive symptoms score.
‡Difference (and SE) in well-being score from the reference group. Figures in square brackets show the difference in standardised well-being
scores from the reference group. ***p≤0.001, **p≤0.01, * p<0.05.
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not ﬁnd an association between recurrent short or long
sleep and overall well-being. However, in accordance
with others,7–9 12 we found an independent association
between chronic insomnia symptoms and lower overall
well-being, which remained even when depressive symp-
toms were taken into account.
Many of the mechanisms suggested as explanations for
the association between insomnia symptoms and well-
being are similar to those suggested for short sleep,11 28
implying that both indicators are simply capturing an
underlying concept of poor quality sleep.36 37 However,
we ﬁnd a dose–response association for insomnia symp-
toms and well-being which is not present for short sleep,
suggesting that there may be different mechanisms for
these associations.
A number of mechanisms may mediate the association
between short sleep and overall or mental well-being,
including fatigue or sleepiness during the day38 and the
involvement of metabolic and endocrine functions.39
The mechanisms linking long sleep and physical well-
being are less clear, possibilities are reverse causation, as
longer sleep may be an early symptom of undiagnosed
disease,10 or increased sleep fragmentation.40 41
However, associations were robust to adjustment for pres-
ence of a limiting long-term illness. Associations
between well-being and physical well-being may also be
subject to confounding by mental health problems such
as depression, where reporting problems with sleep is a
clinical symptom.42 However, the association between
sleep duration and insomnia symptoms remained follow-
ing adjustment for the GHQ depression scale.
We used self-reported measures of both sleep duration
and insomnia symptoms. Observational studies are
beginning to include measures of sleep duration based
on actigraphy data; however, these were not available in
1997, when sleep duration was ﬁrst measured in this
cohort. Also as sleep problems remain self-diagnosed
within the primary care setting, self-reported data can be
assumed to have face validity. Self-reported sleep dur-
ation has shown moderate correlations with more object-
ive measures of sleep, such as actigraphy.43–45 Despite
this, further research will be necessary when long-term
actigraphy measures of sleep are available, since three
measurements in 10 years may not fully describe the
sleep history of participants. Second, we are not able to
take sleep disorders such as sleep apnoea into account.
However, controlling for BMI in our analysis should
reduce potential confounding by sleep apnoea, since
the prevalence of obesity is greater in those with this
sleep condition. There is a potential overlap between
the measures of vitality included in the SF-36 scale and
the Jenkins questionnaire which asks respondents about
waking up feeling ‘tired and worn out’. A sensitivity ana-
lysis was undertaken in the cross-sectional analysis to
examine any potential overlap between these questions
and it was found that removing them had little effect on
the results. The participants in Whitehall II were origin-
ally from an occupational cohort of white-collar workers,
and therefore participants were employed and relatively
healthy; this may limit generalisability. Further caution
should also be exercised extrapolating these conclusions
to a general population, due to drop-outs from the
sample originally enrolled in the study. The strengths of
this work are the availability of three repeat measures of
exposure to short or long sleep and insomnia symptoms
and three validated well-being outcomes for a large
sample of participants from a well-characterised cohort.
We conclude that while chronic insomnia symptoms are
negatively associated with all aspects of well-being.
However, for older adults, recurrent short sleep duration
does not necessarily have a negative effect on overall or
mental well-being, when the effects of insomnia symp-
toms are taken into account. However, extreme sleep
duration is associated with poor physical well-being.
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